COVID-19 疫情对意大利北部一家医院和癌症中心输血医学科的影响。
The impact of COVID-19 outbreak on the Transfusion Medicine Unit of a Northern Italy Hospital and Cancer Centre.
机构信息
Transfusion Medicine Unit, AUSL-IRCCS di Reggio Emilia, Reggio Emilia, Italy.
Department of Medicine and Surgery, Università di Parma, Parma, Italy.
出版信息
Vox Sang. 2022 Feb;117(2):235-242. doi: 10.1111/vox.13174. Epub 2021 Jun 22.
BACKGROUND AND OBJECTIVES
The first wave of coronavirus disease-2019 (COVID-19) dramatically affected the Transfusion Medicine Unit of the Azienda Unità Sanitari Locale - Istituto di Ricovero e Cura a Carattere Scientifico (AUSL-IRCCS) di Reggio Emilia, which faced a total rearrangement of the procedures for donors and patients. This study aims to assess the major implications of COVID-19 on our department, focusing on the blood transfusion chain and therapies, in order to support transfusion specialists in seeking efficient ways to face similar future emergencies.
MATERIALS AND METHODS
This retrospective study compares our Transfusion Medicine Unit data collected between February and May 2020 with the same period in 2017-2019. Data on red blood cells and platelets donations, transfusions and clinical procedures were collected as aggregates from our internal electronic database.
RESULTS
During the lockdown, donor centres were re-organized to reduce the risk of contagion and avoid unnecessary blood collection. Blood donations were re-scheduled to meet the decrease in elective surgery; consequently, plateletapheresis was implemented to supply the reduction of buffycoat-derived platelets. Transfusions significantly decreased together with orthopaedic and vascular surgery, while they were only marginally diminished for both cancer and onco-haematological patients. Reduced procedures for inpatients and outpatients were matched by remote medicine, addressing the need of a constant healthcare support for patients with chronic diseases.
CONCLUSIONS
The described measures were adopted to avoid excessive blood collection and expiration, guarantee the safety of our ward (for both patients and staff) and supply the necessary transfusion therapies. These measures may support the development of appropriate risk management plans and safety procedures for other hospitals and transfusion services that have to face similar events.
背景与目的
2019 年冠状病毒病（COVID-19）的第一波疫情对雷焦艾米利亚的 Azienda Unità Sanitari Locale - Istituto di Ricovero e Cura a Carattere Scientifico（AUSL-IRCCS）的输血医学科产生了巨大影响，该科室的供者和患者程序面临全面调整。本研究旨在评估 COVID-19 对我们科室的主要影响，重点关注输血链和治疗方法，以支持输血专家寻找应对类似未来紧急情况的有效方法。
材料与方法
这项回顾性研究比较了我们输血医学科在 2020 年 2 月至 5 月期间与 2017-2019 年同期收集的数据。从我们的内部电子数据库中收集了红细胞和血小板捐献、输血和临床程序的数据。
结果
在封锁期间，供者中心进行了重组，以降低感染风险并避免不必要的采血。血液捐献被重新安排以满足择期手术的减少；因此，实施了血小板单采术以供应减少的富含血小板的白细胞。输血与矫形和血管外科一起显著减少，而对于癌症和肿瘤血液病患者则略有减少。远程医疗满足了住院和门诊患者程序的减少，为慢性病患者提供了持续的医疗保健支持。
结论
为避免过度采血和过期，保证我们病房（供者和工作人员）的安全，并供应必要的输血治疗，采取了上述措施。这些措施可能支持其他医院和输血服务制定适当的风险管理计划和安全程序，以应对类似事件。
Zotero 插件